New York, NY February 4, 2026— HITLAB today announced a strategic partnership with Sayvant, a digital health company delivering real-time clinical intelligence for acute care. Through this collaboration, HITLAB will support independent evaluation of Sayvant’s platform to help validate its clinical, operational, and financial impact in real-world care settings.

As part of the partnership, HITLAB will conduct a heuristic study of the Sayvant platform, led by the HITLAB Research team. The assessment will focus on usability, acute-care workflow integration, and the ways in which Sayvant supports in-encounter clinical reasoning, documentation quality, and care delivery efficiency.

HITLAB will also review existing performance data to develop evidence-backed assets, including a white paper and peer-reviewed publication. A summary of the study will be presented at the May 2026 HITLAB Innovators Summit in New York City.

“This partnership reflects HITLAB’s mission to help digital health companies build credible, evidence-driven pathways to scale,” said Stan Kachnowski, PhD, Chair and Co-Founder of HITLAB.

“Partnering with HITLAB reinforces our commitment to building clinically credible, evidence-backed technology for acute care,” said Justin Mardjuki, CEO of Sayvant. “HITLAB’s leadership in evaluating healthcare IT helps ensure that the impact of real-time clinical intelligence—on documentation quality, clinician workflow, and care delivery—is measured and communicated with rigor.”